AIM ImmunoTech Inc. (AIM) analyst actions
Rating and price-target actions on AIM in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the AIM overview →
1 measured AIM analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| AIM ImmunoTech Builds Positive Momentum and Reiterates Focus on Driving Ampligen® Clinical Development Toward Pancreatic Cancer Approval | Press release | -0.35% | +5.25% |
Keep exploring
More AIM: earnings → · SEC filings → · AIM overview →